These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


282 related items for PubMed ID: 9447254

  • 1. Viability determination of M.leprae: comparison of normal mouse foot pad and bacillary ATP bioluminescence assay.
    Gupta UD, Katoch K, Natarajan M, Sharma VD, Sharma RK, Shivannavar CT, Katoch VM.
    Acta Leprol; 1997; 10(4):209-12. PubMed ID: 9447254
    [Abstract] [Full Text] [Related]

  • 2. Analysis of quantitative relationship between viability determination in leprosy by MFP, ATP bioluminescence and gene amplification assay.
    Gupta UD, Katoch K, Sharma RK, Singh HB, Natragan M, Singh D, Sharma VD, Chauhan DS, Das R, Srivastava K, Katoch VM.
    Int J Lepr Other Mycobact Dis; 2001 Dec; 69(4):328-34. PubMed ID: 12035294
    [Abstract] [Full Text] [Related]

  • 3. Assessment of viability by normal mouse foot-pad and bacillary ATP bioluminescence assay in multibacillary cases treated with an MDT regimen using conventional as well as newer drugs like minocycline and ofloxacin.
    Gupta UD, Katoch K, Singh HB, Natrajan M, Sharma VD, Katoch VM.
    Indian J Lepr; 2000 Dec; 72(4):437-42. PubMed ID: 11212477
    [Abstract] [Full Text] [Related]

  • 4. Comparative assessment of viability of M.leprae by mouse foot-pad and fluorescent staining techniques.
    Sreevatsa, Katoch VM.
    Indian J Lepr; 1994 Dec; 66(4):455-62. PubMed ID: 7714355
    [Abstract] [Full Text] [Related]

  • 5. Detection of viable organisms in leprosy patients treated with multidrug therapy.
    Gupta UD, Katoch K, Singh HB, Natrajan M, Sharma VD, Katoch VM.
    Acta Leprol; 1999 Dec; 11(3):89-92. PubMed ID: 10544720
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Growth of the ICRC bacilli in the foot-pad of mice.
    Bapat CV, Modak MS.
    Lepr India; 1978 Apr; 50(2):144-55. PubMed ID: 353383
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Minocycline in lepromatous leprosy.
    Fajardo TT, Villahermosa LG, dela Cruz EC, Abalos RM, Franzblau SG, Walsh GP.
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):8-17. PubMed ID: 7730723
    [Abstract] [Full Text] [Related]

  • 15. Treatment of bacilliferous BL/LL cases with combined chemotherapy and immunotherapy.
    Katoch K, Katoch VM, Natrajan M, Bhatia AS, Sreevatsa, Gupta UD, Sharma VD, Shivannavar CT, Patil MA, Bharadwaj VP.
    Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):202-12. PubMed ID: 7602215
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of metabolism and growth of Mycobacterium leprae by gamma irradiation.
    Adams LB, Soileau NA, Battista JR, Krahenbuhl JL.
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):1-10. PubMed ID: 10834063
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Adenosine triphosphate content of Mycobacterium leprae: effect of purification procedures.
    Dhople AM, Storrs EE.
    Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):83-9. PubMed ID: 7042615
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.